002864 盘龙药业
已收盘 11-20 15:00:00
资讯
新帖
简况
股市必读:盘龙药业(002864)11月20日收盘跌7.16%,主力净流出1334.1万元
证券之星 · 02:17
股市必读:盘龙药业(002864)11月20日收盘跌7.16%,主力净流出1334.1万元
盘龙药业(002864)11月18日主力资金净卖出2186.37万元
证券之星 · 11-18
盘龙药业(002864)11月18日主力资金净卖出2186.37万元
盘龙药业:接待中泰证券等多家机构调研
中金财经 · 11-16
盘龙药业:接待中泰证券等多家机构调研
异动快报:盘龙药业(002864)11月9日13点5分触及涨停板
证券之星 · 11-09
异动快报:盘龙药业(002864)11月9日13点5分触及涨停板
股市必读:盘龙药业新发布《2026年前三季度权益分派实施公告》
证券之星 · 11-06
股市必读:盘龙药业新发布《2026年前三季度权益分派实施公告》
盘龙药业(002864)披露2026年前三季度权益分派实施公告,11月04日股价上涨0.55%
证券之星 · 11-04
盘龙药业(002864)披露2026年前三季度权益分派实施公告,11月04日股价上涨0.55%
盘龙药业(002864)披露回购公司股份进展情况公告,11月02日股价上涨2.42%
证券之星 · 11-02
盘龙药业(002864)披露回购公司股份进展情况公告,11月02日股价上涨2.42%
盘龙药业(002864)2026年三季报简析:净利润同比下降37.04%
证券之星 · 10-31
盘龙药业(002864)2026年三季报简析:净利润同比下降37.04%
股市必读:盘龙药业三季报 - 第三季度单季净利润同比下降52.25%
证券之星 · 10-30
股市必读:盘龙药业三季报 - 第三季度单季净利润同比下降52.25%
盘龙药业(002864)9月30日股东户数2.27万户,较上期增加17.73%
证券之星 · 10-29
盘龙药业(002864)9月30日股东户数2.27万户,较上期增加17.73%
图解盘龙药业三季报:第三季度单季净利润同比下降52.25%
证券之星 · 10-29
图解盘龙药业三季报:第三季度单季净利润同比下降52.25%
盘龙药业(002864)披露首次回购公司股份公告,10月21日股价上涨0.94%
证券之星 · 10-21
盘龙药业(002864)披露首次回购公司股份公告,10月21日股价上涨0.94%
补税潮持续:盘龙药业缴清1670万元税费,同步完成235万元首次股份回购
深圳商报·读创 · 10-21
补税潮持续:盘龙药业缴清1670万元税费,同步完成235万元首次股份回购
盘龙健康智创中心启新仪式暨盘龙集团战略发展研讨会在京顺利举行!
中金财经 · 10-14
盘龙健康智创中心启新仪式暨盘龙集团战略发展研讨会在京顺利举行!
股市必读:盘龙药业新发布《关于回购公司股份进展情况的公告》
证券之星 · 10-09
股市必读:盘龙药业新发布《关于回购公司股份进展情况的公告》
股市必读:盘龙药业新发布《关于回购公司股份进展情况的公告》
证券之星 · 10-08
股市必读:盘龙药业新发布《关于回购公司股份进展情况的公告》
股市必读:盘龙药业新发布《第五届董事会第十次会议决议公告》
证券之星 · 09-23
股市必读:盘龙药业新发布《第五届董事会第十次会议决议公告》
盘龙药业(002864)披露调整2026年股票期权激励计划行权价格及数量公告,9月22日股价下跌0.33%
证券之星 · 09-22
盘龙药业(002864)披露调整2026年股票期权激励计划行权价格及数量公告,9月22日股价下跌0.33%
盘龙药业(002864)披露完成工商变更登记并换发营业执照公告,9月11日股价下跌2.61%
证券之星 · 09-11
盘龙药业(002864)披露完成工商变更登记并换发营业执照公告,9月11日股价下跌2.61%
股市必读:盘龙药业新发布《关于回购股份事项前十大股东及前十大无限售条件股东持股情况的公告》
证券之星 · 09-03
股市必读:盘龙药业新发布《关于回购股份事项前十大股东及前十大无限售条件股东持股情况的公告》
加载更多
公司概况
公司名称:
陕西盘龙药业集团股份有限公司
所属行业:
医药制造业
上市日期:
2017-11-16
主营业务:
陕西盘龙药业集团股份有限公司的主营业务是药材规范化种植、药品生产、研发、销售。公司的主要产品是盘龙七片、盘龙七药酒、金茵利胆胶囊、克比热提片、复方醋酸棉酚片、醋酸棉酚原料药、骨胶归珍片、盘龙七贴。截至本报告期末,公司荣获“国家级绿色工厂”及第七届“全国文明单位”,成功取得中国合格评定国家认可委员会(CNAS)实验室认可证书;2026年上半年新增获评“国家知识产权强国建设示范创建对象”“省级高技能人才培训基地”,入选“全国‘双化协同’典型案例”等多项荣誉资质。
发行价格:
10.03
{"stockData":{"symbol":"002864","market":"SZ","secType":"STK","nameCN":"盘龙药业","latestPrice":18.4,"timestamp":1795158219000,"preClose":19.82,"halted":0,"volume":6206154,"delay":0,"changeRate":-0.0716,"floatShares":98596700,"shares":137000000,"eps":0.461,"marketStatus":"已收盘","change":-1.42,"latestTime":"11-20 15:00:00","open":19.27,"high":19.51,"low":18.4,"amount":117000000,"amplitude":0.056,"askPrice":18.4,"askSize":81,"bidPrice":18.38,"bidSize":350,"shortable":0,"etf":0,"ttmEps":0.461,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1795397400000},"marketStatusCode":5,"adr":0,"adjPreClose":19.82,"symbolType":"stock","openAndCloseTimeList":[[1795138200000,1795145400000],[1795150800000,1795158000000]],"highLimit":21.8,"lowLimit":17.84,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":136700928,"isCdr":false,"pbRate":1.59,"roa":"--","peRate":39.913232,"roe":"3.31%","epsLYR":0.92,"committee":0.263345,"marketValue":2515000000,"turnoverRate":0.0629,"status":1,"floatMarketCap":1814000000},"requestUrl":"/m/hq/s/002864","defaultTab":"news","newsList":[{"id":"2685914553","title":"股市必读:盘龙药业(002864)11月20日收盘跌7.16%,主力净流出1334.1万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2685914553","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2685914553?lang=zh_cn&edition=full","pubTime":"2026-11-23 02:17","pubTimestamp":1795371432,"startTime":"0","endTime":"0","summary":"截至2026年11月20日收盘,盘龙药业报收于18.4元,下跌7.16%,换手率6.29%,成交量6.21万手,成交额1.17亿元。当日关注点交易信息汇总:盘龙药业11月20日收盘价18.4元,单日下跌7.16%,主力资金净流出1334.1万元,占总成交额11.38%。交易信息汇总:该股最近90天内获1家机构给予买入评级。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026112300000795.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002864"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2684096802","title":"盘龙药业(002864)11月18日主力资金净卖出2186.37万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2684096802","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2684096802?lang=zh_cn&edition=full","pubTime":"2026-11-18 15:35","pubTimestamp":1794987348,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2026年11月18日收盘,盘龙药业报收于20.11元,下跌6.03%,换手率9.17%,成交量9.04万手,成交额1.84亿元。11月18日的资金流向数据方面,主力资金净流出2186.37万元,占总成交额11.86%,游资资金净流入285.67万元,占总成交额1.55%,散户资金净流入1900.71万元,占总成交额10.31%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026111800025218.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002864","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2683611631","title":"盘龙药业:接待中泰证券等多家机构调研","url":"https://stock-news.laohu8.com/highlight/detail?id=2683611631","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2683611631?lang=zh_cn&edition=full","pubTime":"2026-11-16 20:17","pubTimestamp":1794831441,"startTime":"0","endTime":"0","summary":"览富财经网讯:盘龙药业公告称,公司于11月13日接待中泰证券、开源证券、方正证券、国信证券、长城证券、华鑫证券、华泰证券、中信证券、东方财富证券、红塔证券、招商基金、长安汇通基金、西安博成基金、西部信托、西安江岳私募基金等15家机构及医药分析师、个人投资者、各方媒体等100余人现场参观,党委书记、董事长谢晓林,董事会秘书赵庆波,财务总监朱文锋,研究院副院长齐华锋,董事长助理肖艺轩参与接待。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/ggzixun/20261116/32424634.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK0276","002864","BK0239","600918"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2682587651","title":"异动快报:盘龙药业(002864)11月9日13点5分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2682587651","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2682587651?lang=zh_cn&edition=full","pubTime":"2026-11-09 13:11","pubTimestamp":1794201103,"startTime":"0","endTime":"0","summary":"证券之星11月9日盘中消息,13点5分盘龙药业(002864)触及涨停板。其所属行业中药目前下跌。领涨股为陇神戎发。该股为创新药,保健品,医药概念热股,当日创新药概念上涨0.06%,保健品概念上涨0.03%。11月6日的资金流向数据方面,主力资金净流出59.65万元,占总成交额2.77%,游资资金净流入7.4万元,占总成交额0.34%,散户资金净流入52.24万元,占总成交额2.43%。近5日资金流向一览见下表:盘龙药业主要指标及行业内排名如下:以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026110900006969.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002864","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2681055340","title":"股市必读:盘龙药业新发布《2026年前三季度权益分派实施公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2681055340","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2681055340?lang=zh_cn&edition=full","pubTime":"2026-11-06 01:59","pubTimestamp":1793901550,"startTime":"0","endTime":"0","summary":"截至2026年11月5日收盘,盘龙药业报收于20.34元,上涨0.94%,换手率2.14%,成交量2.11万手,成交额4277.56万元。当日关注点交易信息汇总:11月5日主力资金净流入485.86万元,占总成交额11.36%。公司公告汇总:盘龙药业发布2026年前三季度权益分派实施公告,每10股派发现金红利0.50元(含税),股权登记日为2026年11月10日,除权除息日为2026年11月11日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026110600002107.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002864"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680050710","title":"盘龙药业(002864)披露2026年前三季度权益分派实施公告,11月04日股价上涨0.55%","url":"https://stock-news.laohu8.com/highlight/detail?id=2680050710","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2680050710?lang=zh_cn&edition=full","pubTime":"2026-11-04 22:40","pubTimestamp":1793803259,"startTime":"0","endTime":"0","summary":"截至2026年11月4日收盘,盘龙药业报收于20.15元,较前一交易日上涨0.55%,最新总市值为27.55亿元。近日,盘龙药业发布《2026年前三季度权益分派实施公告》。公告显示,公司2026年前三季度权益分派方案为:以公司总股本136,700,928股扣除回购股份265,075股后的136,435,853股为基数,向全体股东每10股派发现金红利0.50元(含税),不送红股,不以资本公积金转增股本。公司回购专用账户股份不参与本次权益分派。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026110400044224.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002864"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680759605","title":"盘龙药业(002864)披露回购公司股份进展情况公告,11月02日股价上涨2.42%","url":"https://stock-news.laohu8.com/highlight/detail?id=2680759605","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2680759605?lang=zh_cn&edition=full","pubTime":"2026-11-02 19:37","pubTimestamp":1793619436,"startTime":"0","endTime":"0","summary":"截至2026年11月2日收盘,盘龙药业报收于19.88元,较前一交易日上涨2.42%,最新总市值为27.18亿元。该股当日开盘19.44元,最高19.9元,最低19.22元,成交额达4373.06万元,换手率为2.27%。盘龙药业于2026年11月2日发布《关于回购公司股份进展情况的公告》。公告显示,公司于2026年8月26日召开董事会,审议通过以集中竞价交易方式回购公司股份的方案,拟用于员工持股计划或股权激励,回购资金总额为1000万元至2000万元,实施期限为12个月。回购进展符合相关规定。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026110200029898.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002864","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679769225","title":"盘龙药业(002864)2026年三季报简析:净利润同比下降37.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2679769225","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679769225?lang=zh_cn&edition=full","pubTime":"2026-10-31 07:47","pubTimestamp":1793404066,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理,近期盘龙药业发布2026年三季报。根据财报显示,盘龙药业净利润同比下降37.04%。截至本报告期末,公司营业总收入6.18亿元,同比下降26.56%,归母净利润5654.45万元,同比下降37.04%。按单季度数据看,第三季度营业总收入1.95亿元,同比下降26.94%,第三季度归母净利润1416.84万元,同比下降52.25%。去年的净利率为8.42%,算上全部成本后,公司产品或服务的附加值一般。本文数据来源于盘龙药业2026年三季报,仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026103100017042.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002864"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679976253","title":"股市必读:盘龙药业三季报 - 第三季度单季净利润同比下降52.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2679976253","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679976253?lang=zh_cn&edition=full","pubTime":"2026-10-30 07:49","pubTimestamp":1793317773,"startTime":"0","endTime":"0","summary":"业绩披露要点:2026年前三季度归母净利润5654.45万元,同比下降37.04%;第三季度单季归母净利润1416.84万元,同比下降52.25%。公司公告汇总关于2026年前三季度利润分配方案的公告陕西盘龙药业集团股份有限公司于2026年10月27日召开第五届董事会第十一次会议,审议通过2026年前三季度利润分配方案。本次利润分配金额占当期归属于上市公司股东净利润的12.06%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026103000014216.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002864"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679140393","title":"盘龙药业(002864)9月30日股东户数2.27万户,较上期增加17.73%","url":"https://stock-news.laohu8.com/highlight/detail?id=2679140393","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679140393?lang=zh_cn&edition=full","pubTime":"2026-10-29 19:08","pubTimestamp":1793272129,"startTime":"0","endTime":"0","summary":"证券之星消息,近日盘龙药业披露,截至2026年9月30日公司股东户数为2.27万户,较6月30日增加3420.0户,增幅为17.73%。在中药行业个股中,盘龙药业股东户数低于行业平均水平,截至9月30日,中药行业平均股东户数为5.34万户。从股价来看,2026年6月30日至2026年9月30日,盘龙药业区间涨幅为7.54%,在此期间股东户数增加3420.0户,增幅为17.73%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102900045966.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002864"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679376415","title":"图解盘龙药业三季报:第三季度单季净利润同比下降52.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2679376415","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679376415?lang=zh_cn&edition=full","pubTime":"2026-10-29 03:09","pubTimestamp":1793214566,"startTime":"0","endTime":"0","summary":"证券之星消息,盘龙药业2026年三季报显示,前三季度公司主营收入6.18亿元,同比下降26.56%;归母净利润5654.45万元,同比下降37.04%;扣非净利润5111.45万元,同比下降38.02%;其中2026年第三季度,公司单季度主营收入1.95亿元,同比下降26.94%;单季度归母净利润1416.84万元,同比下降52.25%;单季度扣非净利润1262.63万元,同比下降57.36%;负债率25.2%,投资收益-17.49万元,财务费用-826.5万元,毛利率57.69%。财报数据概要请见下图:本文数据来源于盘龙药业2026年三季报,仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102900003719.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002864"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677331608","title":"盘龙药业(002864)披露首次回购公司股份公告,10月21日股价上涨0.94%","url":"https://stock-news.laohu8.com/highlight/detail?id=2677331608","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2677331608?lang=zh_cn&edition=full","pubTime":"2026-10-21 22:50","pubTimestamp":1792594226,"startTime":"0","endTime":"0","summary":"截至2026年10月21日收盘,盘龙药业报收于20.34元,较前一交易日上涨0.94%,最新总市值为27.8亿元。该股当日开盘20.26元,最高20.51元,最低20.23元,成交额达2529.7万元,换手率为1.26%。近日,盘龙药业披露《关于首次回购公司股份的公告》。本次回购符合相关法规及公司既定回购方案。公司已于2026年8月26日审议通过回购股份方案,拟使用自有资金1,000万元至2,000万元回购股份,用于员工持股计划或股权激励,回购价格上限调整为35.82元/股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102100041866.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002864","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677676975","title":"补税潮持续:盘龙药业缴清1670万元税费,同步完成235万元首次股份回购","url":"https://stock-news.laohu8.com/highlight/detail?id=2677676975","media":"深圳商报·读创","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2677676975?lang=zh_cn&edition=full","pubTime":"2026-10-21 19:40","pubTimestamp":1792582804,"startTime":"0","endTime":"0","summary":"10月21日晚间,盘龙药业(002864)发布税务事项公告,公司及其控股子公司本年度自查补缴税款金额累计达到1415万元,滞纳金为255万元,合计补缴税款及滞纳金为1670万元,占公司最近一个会计年度经审计净利润的17.34%。截至公告披露日,上述税款及滞纳金已全部缴纳完毕,且本次补缴事项不涉及行政处罚。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202610213902820059.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202610213902820059.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK0239","002864"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675399655","title":"盘龙健康智创中心启新仪式暨盘龙集团战略发展研讨会在京顺利举行!","url":"https://stock-news.laohu8.com/highlight/detail?id=2675399655","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675399655?lang=zh_cn&edition=full","pubTime":"2026-10-14 09:10","pubTimestamp":1791940201,"startTime":"0","endTime":"0","summary":"10月13日,盘龙药业“盘龙健康智创中心启新仪式暨盘龙集团战略发展研讨会”于北京经济技术开发区(亦庄)举行。随着北京盘龙健康智创中心正式启新,盘龙药业“西安+北京”双总部格局浮出水面,运行多年的“一体两翼三纵深”战略也由此打开全新维度。本次北京盘龙健康智创中心的设立,正是“一体两翼三纵深”战略在研发纵深、营销纵深两大板块的关键落子。","market":"fut","thumbnail":" http://caiji.3g.cnfol.com/colect/202610/14/20261014982848.jpg","type":0,"news_type":0,"thumbnails":[" http://caiji.3g.cnfol.com/colect/202610/14/20261014982848.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/ggzixun/20261014/32395999.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["002864","IBBQ","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674500777","title":"股市必读:盘龙药业新发布《关于回购公司股份进展情况的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2674500777","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674500777?lang=zh_cn&edition=full","pubTime":"2026-10-09 04:00","pubTimestamp":1791489639,"startTime":"0","endTime":"0","summary":"公司公告汇总:截至2026年9月30日,盘龙药业累计回购股份0股,支付金额0元,回购尚未启动。公司公告汇总关于回购公司股份进展情况的公告陕西盘龙药业集团股份有限公司于2026年8月26日召开董事会,审议通过以集中竞价交易方式回购公司股份的方案,拟用于员工持股计划或股权激励,回购资金总额不低于1,000万元且不超过2,000万元,实施期限为12个月。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026100900003130.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002864"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673010946","title":"股市必读:盘龙药业新发布《关于回购公司股份进展情况的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2673010946","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2673010946?lang=zh_cn&edition=full","pubTime":"2026-10-08 03:58","pubTimestamp":1791403089,"startTime":"0","endTime":"0","summary":"截至2026年9月30日收盘,盘龙药业报收于21.05元,上涨0.72%,换手率1.35%,成交量1.34万手,成交额2814.67万元。当日关注点交易信息汇总:9月30日主力资金净流入16.88万元,游资资金净流入91.15万元,散户资金净流出108.03万元。公司公告汇总:截至2026年9月30日,盘龙药业累计回购股份0股,支付金额0元,回购尚未启动。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026100800001851.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002864","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669629121","title":"股市必读:盘龙药业新发布《第五届董事会第十次会议决议公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2669629121","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669629121?lang=zh_cn&edition=full","pubTime":"2026-09-23 02:30","pubTimestamp":1790101834,"startTime":"0","endTime":"0","summary":"关于调整公司2026年股票期权激励计划期权行权价格及数量的公告盘龙药业于2026年9月21日召开第五届董事会第十次会议,审议通过《关于调整公司2026年股票期权激励计划期权行权价格及数量的议案》;调整依据为2025年年度权益分派及2026年半年度权益分派,调整后股票期权数量为485,550份,行权价格为23.64元/份;本次调整无需提交股东会审议,不会对公司财务状况和经营成果产生重大影响。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092300002764.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002864"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669148773","title":"盘龙药业(002864)披露调整2026年股票期权激励计划行权价格及数量公告,9月22日股价下跌0.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2669148773","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669148773?lang=zh_cn&edition=full","pubTime":"2026-09-22 17:46","pubTimestamp":1790070389,"startTime":"0","endTime":"0","summary":"截至2026年9月22日收盘,盘龙药业报收于21.36元,较前一交易日下跌0.33%,最新总市值为29.2亿元。该股当日开盘21.29元,最高21.58元,最低21.13元,成交额达4155.99万元,换手率为1.98%。陕西盘龙药业集团股份有限公司于2026年9月21日召开第五届董事会第十次会议,审议通过了《关于调整公司2026年股票期权激励计划期权行权价格及数量的议案》。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092200031320.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002864","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666578977","title":"盘龙药业(002864)披露完成工商变更登记并换发营业执照公告,9月11日股价下跌2.61%","url":"https://stock-news.laohu8.com/highlight/detail?id=2666578977","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666578977?lang=zh_cn&edition=full","pubTime":"2026-09-11 22:35","pubTimestamp":1789137317,"startTime":"0","endTime":"0","summary":"近日,陕西盘龙药业集团股份有限公司披露《关于公司完成工商变更登记并换发营业执照的公告》。公告显示,公司因实施2025年度利润分配及资本公积金转增股本,以及回购注销2022年限制性股票,导致总股本和注册资本发生变化。变更后公司注册资本由10,628.096万元增至13,670.0928万元,总股本为136,700,928股。相关工商变更手续已办理完毕,并取得陕西省市场监督管理局颁发的新营业执照。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091100050651.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002864"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664846310","title":"股市必读:盘龙药业新发布《关于回购股份事项前十大股东及前十大无限售条件股东持股情况的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2664846310","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664846310?lang=zh_cn&edition=full","pubTime":"2026-09-03 02:50","pubTimestamp":1788375023,"startTime":"0","endTime":"0","summary":"公司公告汇总:披露回购决议前一交易日前十大股东及前十大无限售条件股东持股情况,谢晓林合计持股48,346,912股,其中无限售条件股份12,086,728股。公司公告汇总关于回购股份事项前十大股东及前十大无限售条件股东持股情况的公告陕西盘龙药业集团股份有限公司于2026年8月26日召开第五届董事会第九次会议,审议通过《关于以集中竞价交易方式回购公司股份方案的议案》。截至2026年8月31日,公司尚未实施回购,累计回购股份数量为0股,支付金额为0元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090300002340.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002864"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1795377071083,"stockEarnings":[{"period":"1week","weight":-0.1667},{"period":"1month","weight":-0.0935},{"period":"3month","weight":-0.1426},{"period":"6month","weight":-0.1711},{"period":"1year","weight":-0.2871},{"period":"ytd","weight":-0.212}],"compareEarnings":[{"period":"1week","weight":-0.0277},{"period":"1month","weight":-0.0483},{"period":"3month","weight":-0.0951},{"period":"6month","weight":-0.1408},{"period":"1year","weight":-0.1011},{"period":"ytd","weight":-0.1096}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"陕西盘龙药业集团股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"22714人(较上一季度增加17.73%)","perCapita":"4340股","listingDate":"2017-11-16","address":"陕西省商洛市柞水县盘龙生态产业园","registeredCapital":"13670万元","survey":" 陕西盘龙药业集团股份有限公司的主营业务是药材规范化种植、药品生产、研发、销售。公司的主要产品是盘龙七片、盘龙七药酒、金茵利胆胶囊、克比热提片、复方醋酸棉酚片、醋酸棉酚原料药、骨胶归珍片、盘龙七贴。截至本报告期末,公司荣获“国家级绿色工厂”及第七届“全国文明单位”,成功取得中国合格评定国家认可委员会(CNAS)实验室认可证书;2026年上半年新增获评“国家知识产权强国建设示范创建对象”“省级高技能人才培训基地”,入选“全国‘双化协同’典型案例”等多项荣誉资质。","listedPrice":10.03},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.54.0","shortVersion":"4.54.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"盘龙药业(002864)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供盘龙药业(002864)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"盘龙药业,002864,盘龙药业股票,盘龙药业股票老虎,盘龙药业股票老虎国际,盘龙药业行情,盘龙药业股票行情,盘龙药业股价,盘龙药业股市,盘龙药业股票价格,盘龙药业股票交易,盘龙药业股票购买,盘龙药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"盘龙药业(002864)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供盘龙药业(002864)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}